13:42 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWDprnewswire·2 hours agoFNWD-0.32%BLFS-1.50%
Repligen Corporation Stock 12‑Month Price Target Raised to $177.67, Implies 36% UpsideTradingView·1 day ago, 03:20 PMRGEN-2.83%
Repligen soars 16% after blockbuster earnings, FY25 guidance upgradeMSN·1 day ago, 02:02 PMRGEN-2.83%
RGEN: Raised 2026 guidance after strong Q2 growth, margin gains, and BioLife acquisition announcementQuartr·1 day ago, 09:51 AMBLFS-1.50%RGEN-2.83%
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesdaybenzinga_article·1 day ago, 09:05 AMAWI-2.33%KO+0.92%
Repligen | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 204.13 MEarnings Watch·1 day ago, 06:15 AMRGEN-2.83%
Repligen Q2 GAAP EPS drops 65.38% to $0.09; revenue rises 12% to $204 millionPUBT·1 day ago, 06:14 AMRGEN-2.83%BLFS-1.50%
Bessemer Group Inc. Has $229,000 Holdings in Repligen Corporation $RGENMarket Beat·2 days ago, 02:22 AMRGEN-2.83%
Is Repligen (RGEN) Still Undervalued Following Its $1.5b BioLife Deal?Simplywall·Jul 23 at 08:19 AMRGEN-2.83%BLFS-1.50%
Biotech Stocks At 52-Week Highs - ADVB Surges +73%, BLFS Rises After Acquisition, FBRX, SLN, LBRXrttnews·Jul 23 at 03:38 AMSLN0.00%FBRX-0.16%
BioLife Solutions to Be Acquired by Repligen for $11.25 Cash Plus 0.1442 Share Per ShareTradingView·Jul 22 at 04:23 PMBLFS-1.50%RGEN-2.83%
